Med. praxi. 2010;7(5):221-228

Tratment of atopic dermatitis/eczema in adults

MUDr.Nina Benáková
Dermatovenerologická ordinace Medicínské centrum a Dermatovenerologická klinika 1. LF UK Praha

In the introduction the author informs about the contemporary view on ethiopathogenesis of atopic dermatitis. After practical reviewing

of clinical forms, diagnostics, therapy and it´s principles she presents some recommendations for general practitioners: patients´ education,

searching for triggering factors, prophylaxis, use and examples of emolients, topical corticosteroids and theirs safety regimens.

Some recommendation of educative literature for the patients is added.

Keywords: atopic dermatitis, skin barrier disturbance, diagnostics, emolients, corticosteroids, patients´ education

Published: June 1, 2010  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Benáková N. Tratment of atopic dermatitis/eczema in adults. Med. praxi. 2010;7(5):221-228.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Abramowits W. A clinician paradigm in the tratment of atopic dermatitis. Am Acad Dermatol 2005; 53: 70-76. Go to original source... Go to PubMed...
    2. Benáková N. Ekzémy a dermatitidy. 2. vydání. Praha: Maxdorf, 2009: 125 s.
    3. Benáková N. Atopická dermatitida v roce 2009. Čs. Derm 2009; 84: 65-86.
    4. Bieber T. Mechanism of disease: atopic dermatitis. N Eng J Med, 2008; 358(14): 1483-1495. Go to original source... Go to PubMed...
    5. Cardona ID, Cho SH, Leung DYM. Role of bacterial superantigens in atopic dermatitis. Am J Clin Dermatol, 2006; 7(5): 273-279. Go to original source... Go to PubMed...
    6. Cork MC, Robinson DA, Vasilopoulos Y, et al. New perspectives on epidemal barrier dysfunction in atopic dermatitis: gene-enviroment interactions. J Allergy Clin Immunol, 2006; 118(1): 3-20. Go to original source... Go to PubMed...
    7. Di Carlo JB, Mc Call CO. Pharmacologic alternatives for severe atopic dermatitis. Int J Dermatol, 2001; 40: 82-888. 9. 10. Go to original source... Go to PubMed...
    8. Čapková Š. Možnosti léčby atopické dermatitidy v roce 2008. Farmakoterapie 2008; suppl. 3: 22-31. Go to original source...
    9. Holobradá M. Komplexná liečba atopickej dermatitidy. Derma 2006; 4: 11-15.
    10. Christophers E, Folster-Hostz R. Atopic versus infantile eczema. J Am Acad Dermatol 2001; 45: 4-6. Go to original source... Go to PubMed...
    11. Chromej I. Atopický ekzém. Banská Bystrica: Dali, 2007: 240 s.
    12. Klubal R (koordinátor). Workshop on atopic dermatitis. Praha 26.-28. 4. 2006 a 25.-27. 5. 2007.
    13. Mohrenschlager M, Darsow U, Schnopp C, Ring J. Atopic eczema: what is new? JEADV 2006; 20: 503-511. Go to original source... Go to PubMed...
    14. Olesen AB. Atopic dermatitis- has the epidemic stopped or just begun? In: EADV Congress news 2006; 4.
    15. Pánková R. Psychosociální souvislosti atopické dermatitidy. Referátový výběr 2008; 50(S II): 37-40.
    16. Pónayai G, HidvégiI B, Németh I, et al. Contact and aeroallergens in adulthood atopic dermatitis. JEADV, 2008; 22: 1346-1355. Go to original source... Go to PubMed...
    17. Polášková S. Léčba atopického ekzému. Practicus 2006; 1: 404-406.
    18. Sandilandis A, et al. Prevalent and rare mutations in gene encoding filaggrin cause ichthyosis vulgaris and predispose individuals to atopic dermatitis. J Invest Dermatol 2006; 126: 1770-1775. Go to original source... Go to PubMed...
    19. Thestrup-Pedersen K. Atopic eczema - new insights in definition, diagnostics and disease management. Acta Derm Venereol 2005; Suppl. 215: 7-48.

    Return to the content


    Medicine for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.